INMB Financials
Inmune Bio Inc - Financial statements & key metrics
Stock Price
$1.29
Market Cap
$33.50M
EPS
$-1.86
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$14,000
Gross Profit
-
Operating Income
-
Net Income
$-42.08M
EPS (Diluted)
$-2.11
Balance Sheet Highlights
Total Assets
$39.56M
Total Liabilities
$7.46M
Shareholders Equity
-
Cash & Equivalents
$20.92M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-33.36M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
100.0%
Operating Margin
-617.4%
ROE
-1.7%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is INMB revenue?
INMB's most recent quarterly revenue was $14,000. Annual revenue can be calculated by summing the four most recent quarters.
Is INMB profitable?
INMB reported a loss of $42.08M in the most recent quarter.
What is INMB market cap?
INMB has a market capitalization of $33.50M, making it a small-cap stock.
Does INMB have debt?
View INMB's balance sheet for debt information.
What is INMB cash flow?
Cash flow data is available in the full financial statements.